Fintel reports that on July 21, 2025, TD Cowen downgraded their outlook for Centene (NYSE:CNC) from Buy to Hold. Analyst ...

Centene Corp. (NYSE:CNC) is one of the most oversold S&P 500 stocks so far in 2025. On July 2, Centene’s share price plunged ...

However, for Q1 2025, Centene Corporation (NYSE:CNC) stated that premium and service revenues rose by 17% to $42.5 billion ...

Shares of Centene are trading lower on Thursday, hitting a new 52-week low. A rival's profit warning fueled investor anxiety ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

Centene (CNC) stock and HCA Healthcare (HCA) stock are downgraded at Bank of America based on risks from Trump’s One Big Beautiful Bill Act. Read more here.

Shares of health coverage company Centene (NYSE:CNC) fell 39.4% in the afternoon session after the company unexpectedly withdrew its full-year 2025 financial guidance, citing significantly higher ...

Centene stock (NYSE: CNC) currently trades at $73 per share, roughly 25% below its pre-inflation peak level of $97 seen in August 2022, faring much worse than its peer – Molina Healthcare stock ...

Centene served 24 million medical members as of September, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare Advantage (about 5%).

Investing.com - UBS downgraded Centene (NYSE:CNC) stock rating from Buy to Neutral on Wednesday, slashing its price target to $45.00 from $80.00 following the healthcare company’s withdrawal of ...

UBS downgraded Centene’s stock from Buy to Neutral, citing the company’s withdrawal of guidance and concerns over earnings. The firm projects a significant decline in Centene’s earnings per ...

Centene stock (NYSE: CNC) currently trades at $66 per share, roughly 5% above its level in March 2021, and it has the potential for sizable gains. CNC saw its stock trading at around $85 in late ...